Oragenics, Inc. (OGEN)
0.9307
-0.04
(-3.84%)
USD |
NYAM |
Dec 11, 16:00
0.931
0.00 (0.00%)
After-Hours: 07:19
Oragenics Research and Development Expense (TTM): 3.387M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.13B |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 11.68M |
| Theriva Biologics, Inc. | 10.36M |
| NanoViricides, Inc. | 4.609M |